Registered number
10558818
I R PHARM LTD
Filleted Accounts
31 January 2025
I R PHARM LTD
Registered number: 10558818
Balance Sheet
as at 31 January 2025
Notes 2025 2024
£ £
Current assets
Debtors 3 100 100
Cash at bank and in hand 68,188 63,065
68,288 63,165
Creditors: amounts falling due within one year 4 (28,296) (24,814)
Net current assets 39,992 38,351
Net assets 39,992 38,351
Capital and reserves
Called up share capital 100 100
Profit and loss account 39,892 38,251
Shareholder's funds 39,992 38,351
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Imran Rabbani
Director
Approved by the board on 31 October 2025
I R PHARM LTD
Notes to the Accounts
for the year ended 31 January 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 1 1
3 Debtors 2025 2024
£ £
Other debtors 100 100
4 Creditors: amounts falling due within one year 2025 2024
£ £
Director loan 24,611 12,840
Taxation and social security costs 2,730 11,833
Other creditors 955 141
28,296 24,814
5 Other information
I R PHARM LTD is a private company limited by shares and incorporated in England. Its registered office is:
7 Haughton Road
Handsworth
Birmingham
West Midlands
B20 3LE
I R PHARM LTD 10558818 false 2024-02-01 2025-01-31 2025-01-31 VT Final Accounts April 2025 Imran Rabbani No description of principal activity 10558818 2023-02-01 2024-01-31 10558818 core:WithinOneYear 2024-01-31 10558818 core:ShareCapital 2024-01-31 10558818 core:RetainedEarningsAccumulatedLosses 2024-01-31 10558818 2024-02-01 2025-01-31 10558818 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 10558818 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 10558818 bus:Director40 2024-02-01 2025-01-31 10558818 countries:England 2024-02-01 2025-01-31 10558818 bus:FRS102 2024-02-01 2025-01-31 10558818 bus:FilletedAccounts 2024-02-01 2025-01-31 10558818 2025-01-31 10558818 core:WithinOneYear 2025-01-31 10558818 core:ShareCapital 2025-01-31 10558818 core:RetainedEarningsAccumulatedLosses 2025-01-31 10558818 2024-01-31 iso4217:GBP xbrli:pure